Promise of Low Dose Naltrexone Therapy
Potential Benefits in Cancer, Autoimmune, Neurological ...
Autor:
Elaine A Moore
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referre...
Książka